Wednesday, February 10, 2010, 8:20am EST - Canadian Markets open in 1 hour and 10 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Biovail Corporation (BVF)

 On Feb 9: 13.94 USD   0.00 (0.00%)  
MORE ON BVF
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
BIOVAIL CORP (NYSE:BVF) Delayed quote dataEdit
Last Trade: 13.94 USD
Trade Time: Feb 9
Change: 0.00 (0.00%)
Prev Close: 13.94
Open: N/A
Bid: N/A
Ask: N/A
1y Target Est: 19.25
Day's Range: N/A - N/A
52wk Range: 9.26 - 16.14
Volume: 0
Avg Vol (3m): 1,189,200
Market Cap: 2.21B
P/E (ttm): 6.48
EPS (ttm): 2.15
Div & Yield: 0.65 (4.63%)
Biovail Corporation (BVF)
1d  5d  3m  6m  1y  2y  5y  max 
Free Annual Reports
 Add BVF to Portfolio   Download Data

HEADLINES
• Biovail Enters into License and Collaboration Agreement with Alexza for AZ-004
Business Wire (Wed 7:04am)
• Alexza and Biovail Form Collaboration to Develop and Commercialize AZ-004 (Staccato(R) Loxapine) in North America
PRNewswire (Wed 7:00am)
• InPlay: Biovail enters into license and collaboration agreement with Alexza for AZ-004
Briefing.com (Wed 7:00am)
• Personalized Medicine Through Molecular Diagnostics Growth Rates Should Improve As Unemployment Eases According To Leading Industry Expert From Natixis Bleichroeder
Wall Street Transcript (Mon, Jan 25)
• UPDATE - Biovail says rival generic drug trial too small
at Reuters (Fri, Jan 22)
• Biovail Comments on Proposed Generic Wellbutrin XL® Trial
Business Wire (Fri, Jan 22)
• Study: orphan drug applications doubled in 200s
AP (Wed, Jan 20)
• MedGenesis, Amgen sign partnership
AP (Tue, Jan 12)
• Sector Snap: Generic drugmakers downgraded
AP (Fri, Jan 8)
• Biovail to Present at JPMorgan Healthcare Conference
Business Wire (Wed, Jan 6)
More Headlines for BVF...
ANALYST
EPS Est (next year) (Dec-07) : N/A
EPS Est (in 2 years) (Dec-08) : N/A
Avg Rec (current)*: 2.7
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Biovail Corporation engages in the formulation, clinical testing, registration, manufacture, and commercialization of pharmaceutical products utilizing various drug-delivery technologies in the United States and Canada.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices